NIH #5R01CA237327-05
PEA15 IN DEVELOPMENT OF LIVER CANCER AND ITS THERAPEUTIC IMPLICATION
- Amount
- $340K
- Period
- 2020-02-06 → 2026-01-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
RNA modifications and cancer · Molecular Biology
9 total · 0 active
NIH #5R01CA237327-05
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5R01CA237327-04
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5R01CA237327-03
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
Free Radical Biology and Medicine · 2026-04-30
Journal of the Korean Gastric Cancer Association · 2026-01-01 · 5 citations
eLife · 2025-12-29
Journal of Proteome Research · 2025-12-27
Genes & Genomics · 2025-11-26 · 4 citations
Clinical and Molecular Hepatology · 2025-10-28 · 4 citations
2025-10-10
eLife · 2025-10-10
Fructose and glucose from sugary drinks enhance colorectal cancer metastasis via SORD
Nature Metabolism · 2025-09-19 · 13 citations
Epigenetic modulation of BARD1 to enhance anti-VEGF therapy
Cell Reports Medicine · 2025-09-01 · 2 citations
2025-07-25
eLife · 2025-07-25
ImmunoTargets and Therapy · 2025-07-01
Cancer Research · 2025-04-21
Non-coding RNA RMRP governs RAB31-dependent MMP secretion, enhancing ovarian cancer invasion
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2025-03-06 · 3 citations
Clinical and Molecular Hepatology · 2025-02-27
Cancer Letters · 2024-11-26 · 13 citations
Clinical and Molecular Hepatology · 2024-10-07 · 1 citations
Clinical and Molecular Hepatology · 2024-10-07
Clinical and Molecular Hepatology · 2024-10-02